Woman secures EUR 300,000 compensation after medical drugs linked to her tumours
Fresh Take:
In a groundbreaking decision, the French civil court of Poitiers has awarded compensation to a 55-year-old woman who suffered from meningiomas, a type of brain tumor, linked to hormonal medication Androcur. The pharmaceutical giants Bayer HealthCare, Sandoz, and Viatris Santé, along with her doctor and pharmacist, are held responsible for the damages.
This precedent-setting verdict could prompt an influx of similar cases, according to Romain Sintès, the lawyer representing the complainant.
For over two decades, the woman took Androcur, a drug prescribed to treat hypertrichosis and endometriosis. Since 2013, she has been battling meningiomas, tumors that can lead to severe neurological issues.
For years, the patient has struggled with visual disorders, memory loss, and profound fatigue, alleging that she was not adequately informed about the risks associated with the drug. This, despite a 2008 scientific article suggesting a link between cyproterone acetate, Androcur's active substance, and the development of meningiomas.
The court confirmed the causal relationship between the drug and the tumors in 2018, concluding that the damages resulted from the treatments followed by the patient. Bayer argued that the patient stopped taking Androcur in 2004, a claim the court found unconvincing as it deemed the company failed to promptly and effectively inform consumers about the risks.
Viatris and Sandoz, producers of generic versions of Androcur, were criticized for inadequately alerting consumers to the risk of meningiomas linked to prolonged use of the drug since 2008, especially since 2011.
The pharmaceutical companies are collectively responsible for 97% of the total compensation of approximately 325,000 euros, with an immediate requirement of 25%. The doctor and pharmacist involved share the remaining 3%.
For Sintès, this verdict represents the first recognition in France of the medical community's failure to warn patients about the potential risks of Androcur. He stated, "Despite what the laboratories told us, they had the means to alert about secondary effects particularly serious, incapacitating and irreversible, which they knew since 2008."
In other news, Secretary-General Antonio Guterres has condemned the attack in the USA and the vandalism of Jewish sites in Paris. Stay tuned for updates.
The groundbreaking verdict in France may spur a surge of cases linking hormonal medication and severe neurological disorders, as it holds accountable pharmaceutical companies and medical professionals for neglecting to warn patients about risks. A debate on the responsibility of pharmaceutical companies in providing comprehensive health-and-wellness information, including mental-health, therapies-and-treatments, and nutrition, has arisen, particularly regarding the long-term effects of drugs such as Androcur. In the realm of science, ongoing research into neurological-disorders and their connection to certain medications is crucial to improve health-and-wellness outcomes for individuals worldwide. The Secretary-General calls for global action against acts of violence and the protection of cultural sites, underscoring the importance of promoting peace and understanding among nations.
